Acadia pharmaceuticals appoints allyson mcmillan-youngblood as senior vice president, rare disease franchise

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced the appointment of allyson mcmillan-youngblood as senior vice president, rare disease franchise. in this role allyson will be joining acadia's commercial leadership team with a focus on maximizing the potential of daybue® and preparing for future product launches as the company expands its rare disease portfolio. “we are delighted to welcome allyson to acadia,” said catherine owen adams, chief executive offic.
ACAD Ratings Summary
ACAD Quant Ranking